Law Offices of Thomas J. Lamb

  • About Our Firm
  • Drug Injury
  • Asbestos & Mesothelioma
  • Benzene Diseases
  • Breast Implants
  • Free Case Evaluation
  • FAQs

Birth Control Pills Series: The Devastating Side Effects

December 16, 2016 By Law Offices of Thomas J. Lamb, P.A.

The first article of my blog series on Yaz, Yasmin, Ocella, Gianvi, Safyral, and Beyaz discussed how Yaz in particular was marketed to treat premenstrual dysphoric disorder (PMDD)--before PMDD was even classified as a medical condition--so that the drug manufacturer, Bayer, could increase their profits. In this article, I will provide … [Read more...]

Filed Under: Unsafe Drugs Tagged With: adverse drug effects, Bayer, Beyaz, birth control pills, birth control side effects, blood clots, Cerebrovascular Accidents, CVA, Deep Vein Thrombosis, drospirenone, DRSP, DVT, FDA, FDA drug label warnings, Gianvi, Heart Attack, Myocardial Infarction, Ocella, PE, PMDD, PMDD treatments, Pulmonary Embolism, Safyral, severe PMS treatments, Stroke, venous thromboembolism, VTE, Yasmin, Yaz

Asbestos ban to be announced by federal government next week

December 16, 2016 By Law Offices of Thomas J. Lamb, P.A.

The federal government plans to announce a comprehensive ban on asbestos in Canada next week, CBC News has learned. The country currently allows imports of construction products and automotive parts that contain the toxic fibre, even though Canada no longer exports the material. Asbestos is known to cause deadly cancers and lung diseases, and … [Read more...]

Filed Under: Asbestos, Mesothelioma Tagged With: asbestos, asbestos cancer, asbestos exposure, asbestos-related disease

Long-Term Use Of Prevacid, Prilosec, and Nexium May Lead To Strokes

December 16, 2016 By Law Offices of Thomas J. Lamb, P.A.

In November 2016 we learned about a new study that suggests these popular category heartburn medications, known as proton pump inhibitors (PPIs), may increase the risk of ischemic strokes. From a press release from the American Heart Association, “Popular heartburn medication may increase ischemic stroke risk”, we get the following facts: A … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Ischemic Stroke, Nexium, Prevacid, Prilosec, Strokes

Canada should stop importing deadly asbestos, labour group says

December 13, 2016 By Law Offices of Thomas J. Lamb, P.A.

The Canadian Labour Congress is calling for a ban on asbestos. Exposure to asbestos — a fibrous mineral used in building and construction — is the leading cause of workplace-related death in Canada. Canada stopped exporting asbestos in 2011, and its last asbestos mine closed in 2012. But Canada still imports asbestos for use in construction … [Read more...]

Filed Under: Asbestos, Mesothelioma Tagged With: asbestos, asbestos cancer, asbestos exposure, asbestos-related disease

Treatments to prolong life for mesothelioma patients closer

December 13, 2016 By Law Offices of Thomas J. Lamb, P.A.

Researchers have uncovered a strange way that asbestos-related tumours grow, which could pave the way towards better treatments. The scientists at Adelaide’s Flinders University have found that malignant mesothelioma tumours are able to transform into blood vessels, promoting their own growth. Associate Professor Sonja Klebe said the behaviour … [Read more...]

Filed Under: Asbestos, Mesothelioma Tagged With: asbestos, asbestos cancer, asbestos-related disease, mesothelioma, mesothelioma treatments

Birth Control Pills Series: Creating a Clinical Disorder for Profit

November 18, 2016 By Law Offices of Thomas J. Lamb, P.A.

To start my blog series on Yaz, Yasmin, Ocella, Gianvi, Safyral, and Beyaz, I will focus on Yaz in particular, and one of the conditions that it is prescribed to treat. Though drugs are generally created for the purpose of treating existing medical conditions, this is not always the case.  In fact, corruption in the system can sometimes … [Read more...]

Filed Under: Unsafe Drugs Tagged With: adverse drug effects, Beyaz, birth control pills, birth control side effects, drospirenone, Eli Lilly, Gianvi, John Faubner, med page today, Ocella, pharmaceutical corruption, PMDD, PMDD treatments, Safyral, severe PMS treatments, Yasmin, Yaz

Manufacturers of Depakote Face Lawsuits at Home and Abroad

November 14, 2016 By Law Offices of Thomas J. Lamb, P.A.

Recently, the drug manufacturers of Depakote (valproate) and its derivatives have come under legal fire for failing to warn about the possible side effects of the drug, and blatantly concealing warnings in order to increase their profits. In the United States, AbbVie Inc. (formerly Abbott Laboratories) manufactures Depakote, Depakine, and … [Read more...]

Filed Under: Unsafe Drugs Tagged With: abbott laboratories, abbvie, bipolar drugs, birth defects causes, depacon, depakene, depakine, depakote, drug lawsuits, drug side effects, drugs not to use during pregnancy, epilepsy drugs, sanofi, spina bifida causes

New Paradigms in the Treatment of Mesothelioma and NSCLC: An Overview by Fred Hirsch

November 14, 2016 By Law Offices of Thomas J. Lamb, P.A.

Dr. Haffizulla: Welcome to PracticeUpdate. I’m Dr. Farzanna Haffizulla. Joining me today is Dr. Fred Hirsch, CEO of the International Association for the Study of Lung Cancer, and Professor of Medicine at the University of Colorado in Denver. Dr. Hirsch, thank you, so much, for joining me. Dr. Hirsch: Thank you, so much, for the invitation. Dr. … [Read more...]

Filed Under: Asbestos, Mesothelioma Tagged With: asbestos cancer, mesothelioma, mesothelioma treatments

Myxoid variant epithelioid pleural mesothelioma defines a favourable prognosis group: an analysis of 191 patients with pleural malignant mesothelioma

November 11, 2016 By Law Offices of Thomas J. Lamb, P.A.

Malignant pleural mesothelioma shows marked cytoarchitectural diversity. The aim of the study was to evaluate how morphological phenotype impacted upon overall survival. 191 cases of malignant pleural mesothelioma with available follow-up were identified, examined and classified according to histological types. The epithelioid mesotheliomas were … [Read more...]

Filed Under: Asbestos, Mesothelioma Tagged With: asbestos, asbestos cancer, asbestos-related disease, mesothelioma

Defendants BMS And Pfizer Ask For Eliquis Federal Court Consolidation

November 11, 2016 By Law Offices of Thomas J. Lamb, P.A.

On October 13, 2016 attorneys for Bristol-Myers Squibb Company and Pfizer Inc. filed with the United States Judicial Panel on Multidistrict Litigation (JPML) this court document, “BRISTOL-MYERS SQUIBB COMPANY AND PFIZER INC.’S MOTION FOR TRANSFER OF RELATED ELIQUIS (APIXABAN) PRODUCTS LIABILITY ACTIONS FOR COORDINATED PRETRIAL PROCEEDINGS PURSUANT … [Read more...]

Filed Under: Unsafe Drugs Tagged With: bleeding events, bleeding risk, Eliquis, Gastrointestinal (GI) Bleeds, Uncontrollable Bleeding Events

  • « Previous Page
  • 1
  • …
  • 43
  • 44
  • 45
  • 46
  • 47
  • …
  • 50
  • Next Page »

Find What You Want Here

Get Free Case Evaluation

We encourage you to submit an online Case Evaluation Form form – it is confidential and there is no obligation.

Or call our toll-free number, 800-426-9535, to speak directly to attorney Tom Lamb about your possible case.

Feel Free To Contact Us

Quick Contact Form
 
Send an Email to Tom Lamb

(800) 426-9535

Main Navigation Menu

  • Drug Injury Cases
  • Asbestos-Mesothelioma Cases
  • Benzene Disease Claims
  • GenX Cancer Cases
  • Breast Implant Cases
  • Case Evaluation Menu
  • Quick Contact Form
  • About Our Firm
  • Frequently Asked Questions
  • Medical Records Charges
  • Collection of Articles
  • Sitemap

Lamb Law Office Newsletter

Lamb Law Office Newsletter provides periodic updates about some of the cases that we are working on for clients, as well as an information resource you might find helpful.

Subscribe using Form below.

Subscription Form

* indicates required

Our Other Websites

Drug Injury Law
Drug Injury Watch
Drug Safety Developments
Asbestos & Mesothelioma

Contact Information

Law Offices of Thomas J. Lamb, P.A.
1908 Eastwood Road, Suite 225
Wilmington, North Carolina 28403
910-256-2971 | 800-426-9535
TJL@LambLawOffice.com

  • Home
  • Frequently Asked Questions
  • Disclaimer and Copyright Notices

Copyright © 2021 · Law Offices of Thomas J. Lamb, P.A.